$ARMC
Un Monde International Ltd.

2022 Form 10-K Financial Statement

#000168316823004680 Filed on July 06, 2023

View on sec.gov

Income Statement

Concept 2022 2021
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $36.65K $58.41K
YoY Change -37.25% 937.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $36.65K $58.41K
YoY Change -37.26% 937.48%
Operating Profit -$36.65K -$58.41K
YoY Change -37.25%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$36.65K -$58.41K
YoY Change -37.25% 937.48%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$36.65K -$58.41K
YoY Change -37.26% 937.48%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$7.518K
COMMON SHARES
Basic Shares Outstanding 6.493M shares 6.493M shares
Diluted Shares Outstanding 6.493M shares 6.493M shares

Balance Sheet

Concept 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.7K $62.31K
YoY Change 64.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $102.7K $66.07K
YoY Change 55.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $102.7K $66.07K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $102.7K $66.07K
YoY Change 55.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$102.7K -$66.07K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 2021
OPERATING ACTIVITIES
Net Income -$36.65K -$58.41K
YoY Change -37.26% 937.48%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities -$25.31K -$60.27K
YoY Change -58.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.31K 60.27K
YoY Change -58.0%
NET CHANGE
Cash From Operating Activities -$25.31K -60.27K
Cash From Investing Activities $0.00 0.000
Cash From Financing Activities $25.31K 60.27K
Net Change In Cash $0.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$25.31K -$60.27K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001415813
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-147187
CY2022 dei Entity Registrant Name
EntityRegistrantName
UN MONDE INTERNATIONAL WORLDWIDE LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0500896
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1-45A West Wilmot St
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Richmond Hill
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L4B2P2
CY2022 dei City Area Code
CityAreaCode
905
CY2022 dei Local Phone Number
LocalPhoneNumber
962-0823
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6493346 shares
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2021Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q4 us-gaap Assets
Assets
0 usd
CY2021Q4 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15101 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3764 usd
CY2022Q4 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
87620 usd
CY2021Q4 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
62308 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102721 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66072 usd
CY2022Q4 us-gaap Liabilities
Liabilities
102721 usd
CY2021Q4 us-gaap Liabilities
Liabilities
66072 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2426431 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2389782 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
25312 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
60271 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
33918 usd
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
28139 usd
CY2022 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
2731 usd
CY2021 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
30267 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
36649 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
58406 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-36649 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-58406 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-36649 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-58406 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36649 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-58406 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7666 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-58406 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36649 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-36649 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-58406 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11337 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1865 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25312 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60271 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25312 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60271 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zgJTgRNiZDha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_867_zXT2CQqMDZMk">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zlLzu4Mmj5t3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_860_zppr7vKfcjfa">Concentration of credit risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Financial instruments which potentially subject the Company to concentration of credit risk consist of cash deposits and customer receivables. The Company maintains cash with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions. To reduce risk, the Company performs credit evaluations of its customers and maintains reserves when necessary for potential credit losses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-ten reverse stock split
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1276487 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1276487 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2426631 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2022Q4 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
87620 usd
CY2021Q4 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
62308 usd

Files In Submission

Name View Source Status
0001683168-23-004680-index-headers.html Edgar Link pending
0001683168-23-004680-index.html Edgar Link pending
0001683168-23-004680.txt Edgar Link pending
0001683168-23-004680-xbrl.zip Edgar Link pending
armc-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unmonde_ex3101.htm Edgar Link pending
unmonde_ex3102.htm Edgar Link pending
unmonde_ex3201.htm Edgar Link pending
unmonde_ex3202.htm Edgar Link pending
unmonde_i10k-123122.htm Edgar Link pending
armc-20221231_cal.xml Edgar Link unprocessable
armc-20221231_def.xml Edgar Link unprocessable
armc-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
armc-20221231_pre.xml Edgar Link unprocessable
unmonde_i10k-123122_htm.xml Edgar Link completed